B3GNT5 and cancer: In contrast to this ambiguity, the GlycoEnzOnto ontology suggests that the impact of cancer is likely to be more severe on lactosylceramide biosynthesis initiating enzymes: A4GALT5, B3GALT5, B3GNT5 and B4GALT6 (Fig. 4D).